EP Patent

EP2610239A1 — Preparation Of Rasagiline Hemitartrate

Assigned to Dr Reddys Laboratories Ltd · Expires 2013-07-03 · 13y expired

What this patent protects

The present application provides improved processes for crystallization of Rasagiline hemitartrate having improved filterability.

USPTO Abstract

The present application provides improved processes for crystallization of Rasagiline hemitartrate having improved filterability.

Drugs covered by this patent

Patent Metadata

Patent number
EP2610239A1
Jurisdiction
EP
Classification
—
Expires
2013-07-03
Drug substance claim
No
Drug product claim
No
Assignee
Dr Reddys Laboratories Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.